[Evaluation of the effectiveness of gemfibrozil in primary dyslipoproteinemias. II. Relation between the results of treatment and type of dyslipoproteinemia]

Przegl Lek. 1987;44(12):837-43.
[Article in Polish]
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • English Abstract

MeSH terms

  • Apolipoproteins / blood
  • Cholesterol / blood
  • Clinical Trials as Topic
  • Gemfibrozil
  • Humans
  • Hyperlipoproteinemia Type II / blood
  • Hyperlipoproteinemia Type II / drug therapy*
  • Hyperlipoproteinemia Type IV / blood
  • Hyperlipoproteinemia Type IV / drug therapy*
  • Pentanoic Acids / therapeutic use*
  • Triglycerides / blood
  • Valerates / therapeutic use*

Substances

  • Apolipoproteins
  • Pentanoic Acids
  • Triglycerides
  • Valerates
  • Cholesterol
  • Gemfibrozil